Floatz logo

Prasterone

Long-term Survivors

University of ArkansasPhase 2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Long-term Survivors cohort.

Asset / SponsorPhaseRating
Polycarbophil
University of Arkansas
Phase 2CCC

Same molecule, other indications

Prasterone is also rated in:

postmenopausal atrophic vaginitisDormant
BB
Indicative ·
66 / 100
View asset →
systemic lupus erythematosusDormant
BB
Indicative ·
66 / 100
View asset →
breast cancerDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →